Beryl Drugs Limited (BERLDRG.BO)
INR 19.55
(-3.65%)
INR 19.55
(-3.65%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 48.7 Million INR | 14.36% |
| 2022 | 42.59 Million INR | -15.19% |
| 2021 | 50.22 Million INR | 7.5% |
| 2020 | 46.71 Million INR | -3.45% |
| 2019 | 48.38 Million INR | 53.87% |
| 2018 | 31.44 Million INR | 135.17% |
| 2017 | 13.37 Million INR | 23.94% |
| 2016 | 10.78 Million INR | -31.08% |
| 2015 | 15.65 Million INR | 76.91% |
| 2014 | 8.84 Million INR | -34.37% |
| 2013 | 13.48 Million INR | 110.63% |
| 2012 | 6.4 Million INR | -12.79% |
| 2011 | 7.34 Million INR | -23.36% |
| 2010 | 9.57 Million INR | 28.47% |
| 2009 | 7.45 Million INR | -7.38% |
| 2008 | 8.04 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 48.7 Million INR | 0.0% |
| 2023 FY | 48.7 Million INR | 14.36% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 47.06 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 42.59 Million INR | 0.0% |
| 2022 FY | 42.59 Million INR | -15.19% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 44.34 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 35.24 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 50.22 Million INR | 7.5% |
| 2021 Q4 | 50.22 Million INR | 0.0% |
| 2020 Q2 | 45.09 Million INR | 0.0% |
| 2020 FY | 46.71 Million INR | -3.45% |
| 2020 Q4 | 46.71 Million INR | 0.0% |
| 2019 Q4 | 48.38 Million INR | 0.0% |
| 2019 Q2 | 33.26 Million INR | 0.0% |
| 2019 FY | 48.38 Million INR | 53.87% |
| 2018 Q4 | 31.44 Million INR | 0.0% |
| 2018 FY | 31.44 Million INR | 135.17% |
| 2018 Q2 | 19.83 Million INR | 0.0% |
| 2017 FY | 13.37 Million INR | 23.94% |
| 2017 Q4 | 13.37 Million INR | 0.0% |
| 2017 Q2 | 8 Million INR | 0.0% |
| 2016 Q2 | 16.01 Million INR | 0.0% |
| 2016 Q4 | 9.11 Million INR | 0.0% |
| 2016 FY | 10.78 Million INR | -31.08% |
| 2015 Q4 | 15.65 Million INR | 0.0% |
| 2015 FY | 15.65 Million INR | 76.91% |
| 2015 Q2 | 12.05 Million INR | 0.0% |
| 2014 Q4 | 8.84 Million INR | 0.0% |
| 2014 FY | 8.84 Million INR | -34.37% |
| 2013 FY | 13.48 Million INR | 110.63% |
| 2013 Q4 | 13.48 Million INR | 0.0% |
| 2012 Q4 | 6.4 Million INR | 0.0% |
| 2012 FY | 6.4 Million INR | -12.79% |
| 2011 FY | 7.34 Million INR | -23.36% |
| 2011 Q4 | 7.34 Million INR | 0.0% |
| 2010 FY | 9.57 Million INR | 28.47% |
| 2009 FY | 7.45 Million INR | -7.38% |
| 2008 FY | 8.04 Million INR | 0.0% |
| 2008 Q4 | 8.04 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | 92.741% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 58.1% |
| Bacil Pharma Limited | 569 Thousand INR | -8460.281% |
| Cian Healthcare Limited | 544.97 Million INR | 91.062% |
| Colinz Laboratories Limited | -64.3 Million INR | 175.748% |
| Concord Drugs Limited | 164.48 Million INR | 70.388% |
| Deccan Health Care Limited | -7.07 Million INR | 788.355% |
| Gennex Laboratories Limited | -552.54 Million INR | 108.815% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -28.98% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 201.268% |
| Kerala Ayurveda Limited | 447.82 Million INR | 89.124% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 94.716% |
| Mercury Laboratories Limited | -26.72 Million INR | 282.229% |
| Panchsheel Organics Limited | -157.82 Million INR | 130.863% |
| Parmax Pharma Limited | 51.8 Million INR | 5.987% |
| Parnax Lab Limited | 787.61 Million INR | 93.816% |
| Patidar Buildcon Limited | 25.12 Million INR | -93.855% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -30.626% |
| Phaarmasia Limited | -4.89 Million INR | 1094.65% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 526.142% |
| Sastasundar Ventures Limited | -297.24 Million INR | 116.386% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 209.152% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 183.139% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 95.348% |
| Sunil Healthcare Limited | 625.4 Million INR | 92.212% |
| Syschem (India) Limited | 3.53 Million INR | -1279.049% |
| Trident Lifeline Limited | 117.56 Million INR | 58.568% |
| Transchem Limited | -3.16 Million INR | 1639.93% |
| Tyche Industries Limited | -788.94 Million INR | 106.174% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -26.105% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 163.961% |
| Zenith Healthcare Limited | -25.45 Million INR | 291.334% |
| Zenotech Laboratories Limited | -196.85 Million INR | 124.743% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -93.183% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 88.718% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 904.028% |
| MedPlus Health Services Limited | 8.67 Billion INR | 99.439% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 156.67% |
| Smruthi Organics Limited | 111.28 Million INR | 56.233% |
| Trimurthi Limited | -1.17 Million INR | 4234.103% |
| Zenlabs Ethica Limited | 139.54 Million INR | 65.095% |
| Makers Laboratories Limited | 172.59 Million INR | 71.778% |
| Lactose (India) Limited | 373.97 Million INR | 86.975% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 92.935% |
| Roopa Industries Limited | 216.01 Million INR | 77.452% |
| PANJON LTD. | -12.8 Million INR | 480.294% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -262.276% |
| Anuh Pharma Limited | -69.8 Million INR | 169.775% |
| Crestchem Limited | -1.45 Million INR | 3459.172% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 180.202% |
| PRAVEG LIMITED | -434.98 Million INR | 111.198% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 95.335% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 171.351% |
| Norris Medicines Limited | 214.86 Million INR | 77.331% |
| Denis Chem Lab Limited | -236.28 Million INR | 120.614% |
| Veerhealth Care Limited | -2.38 Million INR | 2142.264% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 106.151% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 91.475% |
| Godavari Drugs Limited | 530.02 Million INR | 90.81% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 623.179% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 63.128% |
| Vivanza Biosciences Limited | 50.02 Million INR | 2.635% |
| Medi-Caps Limited | -3.21 Million INR | 1615.495% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 152.297% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 75.87% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 190.394% |
| Bharat Parenterals Limited | 1.48 Billion INR | 96.728% |
| BDH Industries Limited | -164.47 Million INR | 129.615% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 38.112% |
| Coral Laboratories Limited | -612.82 Million INR | 107.948% |
| Evoq Remedies Limited | 41.14 Million INR | -18.373% |
| Trinity League India Limited | -12 Thousand INR | 406000.0% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 96.509% |
| Natural Capsules Limited | 956.68 Million INR | 94.909% |
| Auro Laboratories Limited | 252.51 Million INR | 80.711% |